(Total Views: 624)
Posted On: 05/18/2020 3:47:45 PM
Post# of 153898
“Now if Gilead is really the invisible hand behind FDA, this move by NP can actually push FDA to approve Leronlimab faster.
For years, CYDY investors have speculated about Gilead’s involvement in CYDY, ranging from a potential partner in HIV, a candidate to buy CYDY out and even as a entity who could be “holding” leronlimab back via influence on the FDA.
One thing is clear after the PR this morning: Leronlimab is 100% on Gilead’s radar right at this moment. The question is how will Gilead respond?
For years, CYDY investors have speculated about Gilead’s involvement in CYDY, ranging from a potential partner in HIV, a candidate to buy CYDY out and even as a entity who could be “holding” leronlimab back via influence on the FDA.
One thing is clear after the PR this morning: Leronlimab is 100% on Gilead’s radar right at this moment. The question is how will Gilead respond?
(7)
(0)
